| Cat.No. | Name | Information |
|---|---|---|
| M1637 | ABT-263 | ABT-263 (Navitoclax) is a potent, orally bioavailable inhibitor of the antiapoptotic Bcl-2 family members Bcl-2, Bcl-x (L), and Bcl-w. |
| M2017 | ABT-199 (Venetoclax) | ABT-199 is a highly potent, orally bioavailable and BCL-2 inhibitor. ABT-199 is the first inhibitor targeting Bcl-2 and PPI. |
| M5273 | S63845 | S63845 is a potent and selective myeloid cell leukemia 1 (MCL1) inhibitor; binds human MCL1 with a Kd of 0.19 nM. |
| M13528 | AZD-5991 | AZD-5991 is a potent and selective Mcl-1 inhibitor with an IC50 of 0.7 nM in FRET assay and a Kd of 0.17 nM in surface plasmon resonance (SPR) assay. |
| M13526 | A-1155463 | A-1155463 is a highly potent and selective BCL-XL inhibitor with an EC50 of 70 nM in Molt-4 cell. |
| M41324 | Bcl-B inhibitor 1 | Bcl-B inhibitor 1 is a Bcl-B inhibitor. |
| M41323 | r8 Bid BH3 | r8 Bid BH3 is a biological active peptide. |
| M41322 | Mcl-1 inhibitor 15 | Mcl-1 inhibitor 15 is a Mcl-1 inhibitor (Ki: 0.02 nM). |
| M41321 | Lacutoclax | Lacutoclax is a Bcl-2 inhibitor with antineoplastic activity. |
| M41320 | Mcl-1 inhibitor 13 | Mcl-1 inhibitor 13 is a MCL-1 inhibitor (Ki: 8.2 nM). |
| M41319 | Mcl-1 inhibitor 12 | Mcl-1 inhibitor 12 is a MCL-1 inhibitor (Ki: 0.22 nM). |
| M41318 | Mcl-1 inhibitor 16 | Mcl-1 inhibitor 16 is a mitochondrial targeting Platinum-based inhibitor of Mcl-1. |
| M41317 | Bcl-2-IN-11 | Bcl-2-IN-11 is a potent and selective Bcl-2 activity inhibitor, with an IC50 of 0.9 nM. |
| M41316 | A-1293102 | A-1293102 is a potent and selective BCL-XL inhibitor that kills BCL-XL-dependent tumor cells. |
| M41315 | Mcl-1 inhibitor 14 | Mcl-1 inhibitor 14 is an inhibitor of myeloid cell leukemia-1 (MCL-1) with an Ki of 0.018 nM and can be used for anticancer research. |
| M38854 | Destruxin B | Destruxin B is one of the cyclodepsipeptides, induces apoptosis via a Bcl-2 Family-dependent mitochondrial pathway in human nonsmall cell lung cancer cells. Destruxin B significantly activates caspase-3 and reduces tumor cell proliferation through caspase-mediated apoptosis in vitro and in vivo. |
| M38853 | 2-Hydroxychalcone | 2-hydroxychalcone, a natural flavonoid, is a potent antioxidant, inhibiting lipid peroxidation. 2-Hydroxychalcone induces apoptosis by Bcl-2 downregulation. 2-Hydroxychalcone inhibits the activation of NF-kB. |
| M30525 | Mcl1-IN-1 | Mcl1-IN-1 is an inhibitor of myeloid cell factor 1 (Mcl-1) (IC50=2.4 µM). |
| M30471 | CLZ-8 | CLZ-8 (Compound 8) is an orally active Mcl-1-PUMA interface inhibitor, with a Ki of 0.3 μM. CLZ-8 exhibits dual activity on reduce PUMA-dependent apoptosis while deactivating Mcl-1-mediated anti-apoptosis in cancer cells. |
| M29850 | IMB-XH1 | IMB-XH1 is an inhibitor of myeloid cell factor 1 (Mcl-1). IMB-XH1 is a non-competitive Delhi metallo-β-lactamase (NDM-1) inhibitor. The IC50s of IMB-XH1 against metallo-β-lactamases NDM-1, IMP-4, ImiS and L1 are 0.4637 μM, 3.980 μM, 0.2287 μM and 1.158 μM, respectively. |
| M29579 | CCT373566 | CCT373566 is a potent and orally active degrader of transcriptional repressor BCL6, with an IC50 of 2.2 nM. CCT373566 shows strong antiproliferative efficacy in vitro and reduction in tumor growth in vivo. |
| M29532 | OICR12694 TFA | OICR12694 (JNJ-65234637) TFA is an orally active inhibitor of B cell lymphoma 6 (BCL6). |
| M29531 | OICR12694 | OICR12694 (JNJ-65234637) is an orally active inhibitor of B cell lymphoma 6 (BCL6). |
| M29431 | NPB | NPB is a specific and potent inhibitor of BAD phosphorylation at Ser99, with an IC50 of 0.41 μM. |
| M29424 | Murizatoclax | Murizatoclax (AMG 397) is a potent, selective and orally active inhibitor of myeloid leukemia 1 (MCL-1) inhibitor, with a Ki of 15 pM. Murizatoclax competitive binds to the BH3-binding groove of MCL1 with pro-apoptotic BCL-2 family members. Murizatoclax can be used for the research of cancer. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
